Skip to content
naulon

Not checked for notices yet.

Enhancing the clinical activity of sorafenib through dose escalation: rationale and current experience

Thomas J. Semrad, David R. Gandara, Primo N. Lara

Therapeutic Advances in Medical Oncology · 2011

doi:10.1177/1758834010396117

Cited by papers we hold 1

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.